Skip Navigation

Cardiovascular Research 2005 68(1):136-143; doi:10.1016/j.cardiores.2005.05.016
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sluijter, J. P.G.
Right arrow Articles by de Kleijn, D. P.V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sluijter, J. P.G.
Right arrow Articles by de Kleijn, D. P.V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005, European Society of Cardiology

Involvement of furin-like proprotein convertases in the arterial response to injury

Joost P.G. Sluijtera,b, Robert E. Verloopa, Wilco P.C. Pulskensa, Evelyn Velemaa, Jos M. Grimbergenc, Paul H. Quaxc,d, Marie-José Goumansa, Gerard Pasterkampa and Dominique P.V. de Kleijna,b,*

aExperimental Cardiology Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands
bInteruniversity Cardiology Institute of the Netherlands (ICIN), Utrecht, The Netherlands
cGaubius Laboratory TNO-PG, Leiden, The Netherlands
dDepartment of Surgery, Leiden University Medical Center, Leiden, The Netherlands

* Corresponding author. University Medical Center, Experimental Cardiology Laboratory, Heidelberglaan 100, Room G02-523, 3584 CX Utrecht, The Netherlands. Tel.: +31 30 2507155; fax: +31 30 2522693. Email address: d.dekleijn{at}hli.azu.nl

Background: Furin-like proprotein convertases (PCs) are proteolytic activators of proproteins, like membrane type 1-matrix metalloproteinase (MT1-MMP) and transforming growth factor β (TGF-β), that are described in the arterial response to injury. However, the involvement of furin-like PCs in the arterial response to injury has not been studied yet. We studied furin, MT1-MMP, MMP levels and TGF-β signaling after arterial injury. We also investigated the effect of an inhibitor of furin-like PCs, {alpha}1-antitrypsin Portland ({alpha}1-PDX), on arterial injury following balloon dilation.

Methods and results: NZW rabbit femoral and iliac arteries (N = 42) were balloon dilated unilaterally and harvested after 2, 7, 14, 28 or 42 days. Furin mRNA levels were increased after 2 and 7 days. MMP-2 and MT1-MMP levels were increased after day 7 and TGF-β signaling, by phosphorylating Smad 1/5 and 2/3, was increased at all time points. Inhibition of furin-like PCs, by adenoviral over-expression of {alpha}1-PDX, blocked proTGF-β activation and Smad phosphorylation, and reduced MT1-MMP and MMP-2 activation (N = 5). In vivo adventitial inhibition of furin-like PCs (N = 9) resulted in a reduction of 13.1 ± 5.2% in advential and 23.6 ± 7.9% in intimal areas (P<0.05), but had no effect on lumen size due to decreased vessel areas.

Conclusions: This study demonstrates that furin-like PCs are involved in the arterial response to injury possibly through activation of the TGF-β–Smad signaling pathway and identifies furin-like PCs as a possible target to inhibit intimal hyperplasia.

KEYWORDS Gene therapy; Remodeling; Balloon dilation; Transforming growth factor β (TGF-β); Matrix metalloproteinases


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
R. Khan, A. Agrotis, and A. Bobik
Understanding the role of transforming growth factor-{beta}1 in intimal thickening after vascular injury
Cardiovasc Res, May 1, 2007; 74(2): 223 - 234.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Bobik
Transforming Growth Factor-{beta}s and Vascular Disorders
Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1712 - 1720.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. P.G. Sluijter, D. P.V. de Kleijn, and G. Pasterkamp
Vascular remodeling and protease inhibition-bench to bedside
Cardiovasc Res, February 15, 2006; 69(3): 595 - 603.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.